Flyer

Health Science Journal

  • ISSN: 1791-809X
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Abstract

QUALITY OF LIFE AMONG END STAGE RENAL DISEASE PATIENTS WITH HEMODIALYSIS, AT ARAR, KINGDOM OF SAUDIARABIA

Dr .Hayat Al Zahrani*, Dr.Sobha Saseendrababu and Mrs. Ajitha Thankarajan Rejennal

End-stage renal disease (ESRD) affects the lives of a disproportionate amount of people around the world today. It is estimated that there is 35% increase in the number of dialysis patients worldwide (Oxford Journals, February 2014). According to Ji.Cheng Lv and Lu-Xia-Zhang,2019) Chronic kidney disease (CKD) has been recognized as a leading public health problem worldwide. The global estimated prevalence of CKD is 13.4% (11.7-15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy is estimated between 4.902 and 7.083 million. Through its effect on cardiovascular risk and ESKD, CKD directly affects the global burden of morbidity and mortality worldwide. The global increase in this disease is mainly driven by the increase in the prevalence of diabetes mellitus, hypertension, obesity, and aging.

Keywords ESRD Patients; Hemodialysis; Renal Disease

Published Date: 2022-11-16; Received Date: 2022-10-18